Austar Lifesciences Limited (HKG:6118)
Hong Kong
· Delayed Price · Currency is HKD 0.720
+0.010 (1.41%)
Mar 10, 2026, 4:08 PM HKT
Austar Lifesciences Market Cap
Austar Lifesciences has a market cap or net worth of 363.93 million as of March 10, 2026. Its market cap has increased by 22.41% in one year.
Market Cap
363.93M
Enterprise Value
574.88M
Revenue
1.60B
Ranking
n/a
PE Ratio
9.44
Stock Price
0.72
Market Cap Chart
Since November 7, 2014, Austar Lifesciences's market cap has decreased from 1.79B to 363.93M, a decrease of -79.61%. That is a compound annual growth rate of -13.08%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rainmed Medical | 406.39M |
| Suzhou Basecare Medical Corporation | 514.23M |
| Yestar Healthcare Holdings Company | 261.14M |
| Vincent Medical Holdings | 659.27M |
| Broncus Holding | 727.37M |
| Gaush Meditech | 860.33M |
| Venus Medtech (Hangzhou) | 1.04B |
| Cryofocus Medtech (Shanghai) | 1.36B |